|
EconStor >
Scienpress Ltd, London >
Advances in Management & Applied Economics >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10419/49024
|
| | |
| Title: | | Does increased price competition reduce entry of new pharmaceutical products?  |
| Authors: | | Granlund, David Rudholm, Niklas |
| Issue Date: | | 2011 |
| Citation: | | [Journal:] Advances in Management & Applied Economics [ISSN:] 1792-7552 [Volume:] 1 [Year:] 2011 [Issue:] 1 [Pages:] 1-14 |
| Abstract: | | In October 2002, a substitution reform was introduced in the Swedish pharmaceuticals market. In this paper, the effects of increased price competition due to the reform on the entry of new pharmaceutical products were studied. The results show that the reform did affect the entry behavior of generic manufacturers as they became more prone to enter new package sizes into the market after the reform, but also that there is considerable heterogeneity in entry behavior between different ATC-code groups for both brand name and generic products. |
| Subjects: | | pharmaceutical industry generic competition generic drugs brand name drugs |
| JEL: | | D80 D83 L65 I11 |
| Document Type: | | Article |
| Appears in Collections: | | Advances in Management & Applied Economics
|
| |
| | |
Download bibliographical data as:
BibTeX
|
| |
Share on:http://hdl.handle.net/10419/49024
|
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.
|